Growth & profitability
- Revenue has grown 0.0% per year over the past 5 years.
Financial health
- Operating income covered interest expense -1711.1× in the latest year.
10 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | — | $5M | — | — | — | — | $14M |
| 2024 | — | -$68M | — | — | — | — | $47M |
| 2023 | — | -$81M | — | — | — | — | $71M |
| 2022 | — | -$55M | — | — | — | — | $66M |
| 2021 | $2M | -$41M | 0.0% | -2761.7% | — | — | $115M |
| 2020 | $2M | -$28M | 0.0% | -1902.6% | — | — | $52M |
| 2019 | — | -$33M | — | — | -$27M | — | $4M |
| 2018 | — | -$23M | — | — | — | — | $16M |
| 2017 | — | -$30M | — | — | -$22M | — | $26M |
| 2016 | — | -$26M | — | — | -$25M | — | $793000 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | — | -$77M | — | — | — | — | $7M |
| Dec '25 | — | $40M | — | — | — | — | $14M |
| Sep '25 | — | -$3M | — | — | — | — | $10M |
| Jun '25 | — | -$17M | — | — | — | — | $18M |
| Mar '25 | — | -$15M | — | — | — | — | $33M |
| Dec '24 | — | -$15M | — | — | — | — | $47M |
| Sep '24 | — | -$18M | — | — | — | — | $63M |
| Jun '24 | — | -$20M | — | — | — | — | $78M |
| Mar '24 | — | -$14M | — | — | — | — | $55M |
| Dec '23 | — | -$12M | — | — | — | — | $71M |
| Sep '23 | — | -$14M | — | — | — | — | $81M |
| Jun '23 | — | -$13M | — | — | — | — | $91M |
| Mar '23 | — | -$42M | — | — | — | — | $102M |
| Dec '22 | — | -$12M | — | — | — | — | $66M |
| Sep '22 | — | -$15M | — | — | — | — | $78M |
| Jun '22 | — | -$17M | — | — | — | — | $91M |
| Mar '22 | — | -$10M | — | — | — | — | $103M |
| Dec '21 | $375000 | -$11M | 0.0% | -2796.8% | — | — | $115M |
| Sep '21 | $375000 | -$11M | 0.0% | -3237.3% | — | — | $125M |
| Jun '21 | $375000 | -$10M | 0.0% | -2566.9% | — | — | $36M |
How the market has priced CYPH against its own fundamentals since 2025-11 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, CYPHERPUNK TECHNOLOGIES INC.'s revenue has grown 0.0% per year. These are computed facts, not advice.
As of FY2025, CYPHERPUNK TECHNOLOGIES INC. reported — of total debt against $14M of cash; operating income covered interest expense -1711.1×.
In FY2025, gross margin was —, operating margin —, and net margin —.
As of Jun '26, CYPHERPUNK TECHNOLOGIES INC. traded at a price-to-earnings ratio of about 12.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.